ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

INBX Inhibrx Inc

34.15
0.14 (0.41%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Inhibrx Inc INBX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.14 0.41% 34.15 06:22:21
始値 安値 高値 終値 前日終値
34.35 33.87 34.45 34.15 34.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1205:26EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0906:08EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0905:28EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0706:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0604:58EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0508:26EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0107:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2024/2/2823:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
2024/2/2823:12EDGAR2Form 8-K - Current report
2024/2/2823:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1506:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0706:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2702:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
2024/1/2407:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2320:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2320:35EDGAR2Form 8-K - Current report
2024/1/2320:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
2024/1/2319:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
2024/1/2315:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
2023/11/1006:03EDGAR2Form 8-K - Current report
2023/11/1006:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
2023/11/0222:16EDGAR2Form 8-K - Current report
2023/11/0222:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
2023/10/1905:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
2023/9/2005:03EDGAR2Form 8-K - Current report
2023/9/2005:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
2023/9/0105:06EDGAR2Form D - Notice of Exempt Offering of Securities
2023/8/2922:03EDGAR2Form 8-K - Current report
2023/8/2922:00PRNUSInhibrx Announces $200 Million Private Placement Financing
2023/8/0805:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
2023/5/3022:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
2023/5/3022:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
2023/5/0905:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock